Heat shock proteins in cancer immunotherapy

Heiichiro Udono, R. Suto, Y. Tamura, T. Matsutake, P. K. Srivastava

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Transporter associated with antigen processing (TAP)-translocated peptides into the endoplasmic reticulum (ER) were demonstrated to bind to heat shock protein (HSP) gp96. In addition, TAP independently translocated peptides into the ER appears to bind to gp96. Also, tumor antigen peptide and its precursors were shown to be associated with cytosolic hsp90, hsp70 as well as ER luminal HSP gp96. These evidences are fully consistent with previous speculation that HSPs are associated with an entire repertoire of endogenous peptides destined to be major histocompatibility complex (MHC) class I ligands, which makes it possible to cross-prime across the MHC barrier. Vaccination of mice with HSPs covalently or non-covalently conjugated with synthetic peptides or protein in vitro have led to the generation of peptide specific cytotoxic T lymphocytes (CTLs) and conferred protective immunity against the pathogens or tumor growth in vivo. These observations have been repeatedly confirmed in a number of different model systems. Vaccination effect by HSPs for eradication of tumors which already existed has also been examined and shown to be effective especially in lung metastasis from local tumor. The possibility of cancer immunity elicited by peptides chaperoned by tumor-derived HSPs is now stimulating more than curiosity, and is becoming a solid rationale in terms of T cell priming in vivo; it also may provide a key to open a new avenue to the study of antigen processing/presentation.

Original languageEnglish
Pages (from-to)201-209
Number of pages9
JournalGann Monographs on Cancer Research
Volume48
Publication statusPublished - 1999
Externally publishedYes

Fingerprint

Heat-Shock Proteins
Immunotherapy
Peptides
Endoplasmic Reticulum
Neoplasms
Antigen Presentation
trypsinogen activation peptide
Major Histocompatibility Complex
Immunity
Vaccination
Exploratory Behavior
Cytotoxic T-Lymphocytes
Neoplasm Antigens
Neoplasm Metastasis
Ligands
T-Lymphocytes
Lung
Growth
Proteins

ASJC Scopus subject areas

  • Cancer Research

Cite this

Udono, H., Suto, R., Tamura, Y., Matsutake, T., & Srivastava, P. K. (1999). Heat shock proteins in cancer immunotherapy. Gann Monographs on Cancer Research, 48, 201-209.

Heat shock proteins in cancer immunotherapy. / Udono, Heiichiro; Suto, R.; Tamura, Y.; Matsutake, T.; Srivastava, P. K.

In: Gann Monographs on Cancer Research, Vol. 48, 1999, p. 201-209.

Research output: Contribution to journalArticle

Udono, H, Suto, R, Tamura, Y, Matsutake, T & Srivastava, PK 1999, 'Heat shock proteins in cancer immunotherapy', Gann Monographs on Cancer Research, vol. 48, pp. 201-209.
Udono H, Suto R, Tamura Y, Matsutake T, Srivastava PK. Heat shock proteins in cancer immunotherapy. Gann Monographs on Cancer Research. 1999;48:201-209.
Udono, Heiichiro ; Suto, R. ; Tamura, Y. ; Matsutake, T. ; Srivastava, P. K. / Heat shock proteins in cancer immunotherapy. In: Gann Monographs on Cancer Research. 1999 ; Vol. 48. pp. 201-209.
@article{bff5aaa6248345a6bd892ad71f9a811f,
title = "Heat shock proteins in cancer immunotherapy",
abstract = "Transporter associated with antigen processing (TAP)-translocated peptides into the endoplasmic reticulum (ER) were demonstrated to bind to heat shock protein (HSP) gp96. In addition, TAP independently translocated peptides into the ER appears to bind to gp96. Also, tumor antigen peptide and its precursors were shown to be associated with cytosolic hsp90, hsp70 as well as ER luminal HSP gp96. These evidences are fully consistent with previous speculation that HSPs are associated with an entire repertoire of endogenous peptides destined to be major histocompatibility complex (MHC) class I ligands, which makes it possible to cross-prime across the MHC barrier. Vaccination of mice with HSPs covalently or non-covalently conjugated with synthetic peptides or protein in vitro have led to the generation of peptide specific cytotoxic T lymphocytes (CTLs) and conferred protective immunity against the pathogens or tumor growth in vivo. These observations have been repeatedly confirmed in a number of different model systems. Vaccination effect by HSPs for eradication of tumors which already existed has also been examined and shown to be effective especially in lung metastasis from local tumor. The possibility of cancer immunity elicited by peptides chaperoned by tumor-derived HSPs is now stimulating more than curiosity, and is becoming a solid rationale in terms of T cell priming in vivo; it also may provide a key to open a new avenue to the study of antigen processing/presentation.",
author = "Heiichiro Udono and R. Suto and Y. Tamura and T. Matsutake and Srivastava, {P. K.}",
year = "1999",
language = "English",
volume = "48",
pages = "201--209",
journal = "Gann Monographs on Cancer Research",
issn = "0072-0151",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Heat shock proteins in cancer immunotherapy

AU - Udono, Heiichiro

AU - Suto, R.

AU - Tamura, Y.

AU - Matsutake, T.

AU - Srivastava, P. K.

PY - 1999

Y1 - 1999

N2 - Transporter associated with antigen processing (TAP)-translocated peptides into the endoplasmic reticulum (ER) were demonstrated to bind to heat shock protein (HSP) gp96. In addition, TAP independently translocated peptides into the ER appears to bind to gp96. Also, tumor antigen peptide and its precursors were shown to be associated with cytosolic hsp90, hsp70 as well as ER luminal HSP gp96. These evidences are fully consistent with previous speculation that HSPs are associated with an entire repertoire of endogenous peptides destined to be major histocompatibility complex (MHC) class I ligands, which makes it possible to cross-prime across the MHC barrier. Vaccination of mice with HSPs covalently or non-covalently conjugated with synthetic peptides or protein in vitro have led to the generation of peptide specific cytotoxic T lymphocytes (CTLs) and conferred protective immunity against the pathogens or tumor growth in vivo. These observations have been repeatedly confirmed in a number of different model systems. Vaccination effect by HSPs for eradication of tumors which already existed has also been examined and shown to be effective especially in lung metastasis from local tumor. The possibility of cancer immunity elicited by peptides chaperoned by tumor-derived HSPs is now stimulating more than curiosity, and is becoming a solid rationale in terms of T cell priming in vivo; it also may provide a key to open a new avenue to the study of antigen processing/presentation.

AB - Transporter associated with antigen processing (TAP)-translocated peptides into the endoplasmic reticulum (ER) were demonstrated to bind to heat shock protein (HSP) gp96. In addition, TAP independently translocated peptides into the ER appears to bind to gp96. Also, tumor antigen peptide and its precursors were shown to be associated with cytosolic hsp90, hsp70 as well as ER luminal HSP gp96. These evidences are fully consistent with previous speculation that HSPs are associated with an entire repertoire of endogenous peptides destined to be major histocompatibility complex (MHC) class I ligands, which makes it possible to cross-prime across the MHC barrier. Vaccination of mice with HSPs covalently or non-covalently conjugated with synthetic peptides or protein in vitro have led to the generation of peptide specific cytotoxic T lymphocytes (CTLs) and conferred protective immunity against the pathogens or tumor growth in vivo. These observations have been repeatedly confirmed in a number of different model systems. Vaccination effect by HSPs for eradication of tumors which already existed has also been examined and shown to be effective especially in lung metastasis from local tumor. The possibility of cancer immunity elicited by peptides chaperoned by tumor-derived HSPs is now stimulating more than curiosity, and is becoming a solid rationale in terms of T cell priming in vivo; it also may provide a key to open a new avenue to the study of antigen processing/presentation.

UR - http://www.scopus.com/inward/record.url?scp=0033302920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033302920&partnerID=8YFLogxK

M3 - Article

VL - 48

SP - 201

EP - 209

JO - Gann Monographs on Cancer Research

JF - Gann Monographs on Cancer Research

SN - 0072-0151

ER -